Florence Nightingale: Nursing Pioneer Box Office Collection, Budget & Verdict
Financial Breakdown
| Category | Amount (Approx) |
|---|---|
| Official Budget | TBA |
| Worldwide Gross | TBA |
| IMDb Rating | / 10 |
Detailed Financial Report
Florence Nightingale: Nursing Pioneer, released in 2021, entered the cinematic marketplace with the goal of capturing global audiences. Production insiders estimate the budget to be around an undisclosed amount. This figure typically includes principal photography, talent fees, and post-production costs, but often excludes marketing and distribution expenses which can add another 30-50% to the total investment.
Collection Trajectory
The box office journey for Florence Nightingale: Nursing Pioneer has culminated in a worldwide gross of approximately TBA. While it found an audience, the box office returns faced stiff competition from other releases.
Profitability & Verdict
In the modern film economy, theatrical revenue is just one slice of the pie. However, it remains the primary indicator of a film's "Hit" or "Flop" status. Based on the reported numbers and audience reception (7.8/10), Florence Nightingale: Nursing Pioneer is effectively categorized as a Commercial Success.
Comparables
As a representative of 2021's Documentary, Florence Nightingale: Nursing Pioneer offers a case study in how audience preferences are shifting. Its performance will likely influence studio decisions for future projects in this category.
Frequently Asked Questions
How much did Florence Nightingale: Nursing Pioneer earn at the box office?
Florence Nightingale: Nursing Pioneer has grossed approximately TBA worldwide as of our latest data updating this 2021 report.
What was the production budget for Florence Nightingale: Nursing Pioneer?
The reported production cost for Florence Nightingale: Nursing Pioneer was roughly TBA, excluding marketing and distribution.
Is Florence Nightingale: Nursing Pioneer a box office hit or flop?
Based on its worldwide collection of TBA against a budget of TBA, the film's rating is 7.8/10, indicating it was a commercial success.